She lost 110 pounds on a $199 weight loss drug. Knowing the risks, she’s still taking it.
Tobi Ness credits a cheaper, off-brand GLP-1 drug with saving her life. But the company that sold it…
Warning over online pharmacies claiming to be linked to Grimsby’s hospital
NHS Humber Health Partnership said ‘we do not operate any online pharmaceutical companies, even if they are claiming…
Thinking About Stopping an Antidepressant? Here’s What to Consider.
Earlier this month, Health Secretary Robert F. Kennedy Jr. announced initiatives aimed at getting more people to stop…
Biggest T1D development in over 100 years
THE Therapeutic Goods Administration has approved the biologic therapy Tzield (teplizumab, Sanofi), the first non-insulin therapy for type…
Two-dose nasal spray could reverse brain aging
One spray could turn back the clock. Scientists have developed a therapy that they say could reverse brain…
Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics – National
Some Canadians will be able to buy brand-name GLP-1 drug Ozempic at a reduced price, Danish drugmaker Novo…
Weight Loss: Lilly’s New Drug Helped People Lose Up to 85 Pounds
Share on PinterestA new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1…
NHS alert issued over pharmacies claiming Grimsby hospital link
“We know of one person who’s bought medication online from one of these websites but hasn’t received any…
5 Simple Weight-Loss Tips From Man Who Lost 70 Pounds Without GLP-1 Drug
Nathan Coleman still remembers the exact moment he vowed to lose weight — a “turning point” that led…
SAHPRA clamps down on illegal weight-loss drugs amid safety concerns
The South African Health Products Regulatory Authority (SAHPRA), in a decisive move to protect public health, has intensified…
Thinning revenues: inside the $14bn Eliquis patent cliff
Eliquis (apixaban) is one of the most commercially consequential loss-of-exclusivity (LOE) events in recent pharmaceutical history, with patent…
GLP-1s are fueling a rise of a bizarre, rare ear disorder
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…